FGFR2::TACC2 fusion as a novel KIT‐independent mechanism of targeted therapy failure in a multidrug‐resistant gastrointestinal stromal tumor
暂无分享,去创建一个
Chad M. Vanderbilt | C. Antonescu | S. Singer | W. Tap | P. Chi | B. Untch | J. Dermawan | Jason C. Chang | C. Vanderbilt | Ping Chi